• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 09/19/14

    • 30-Day SEC Yield1

      1.80%
    • Total Net Assets

      $386.6M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2014
  • Portfolio Composition (%)
    as of 09/19/14

    • % of Net Assets
    • Stocks

      100.13
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.13
  • Download All HoldingsAll Holdings (%)as of 09/19/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    376,317
    40,638,47310.51
    Novartis Ag
    NVS US
    404,458
    37,978,6069.82
    Pfizer Inc
    PFE US
    894,865
    27,203,8967.04
    Merck & Co Inc
    MRK US
    358,150
    21,664,4945.60
    Sanofi
    SNY US
    358,509
    20,323,8755.26
    Novo Nordisk A/S
    NVO US
    398,747
    19,303,3424.99
    Actavis Plc
    ACT US
    75,209
    18,186,2884.70
    Eli Lilly & Co
    LLY US
    268,053
    17,833,5664.61
    Bristol-Myers Squibb Co
    BMY US
    339,463
    17,485,7394.52
    Abbott Laboratories
    ABT US
    398,528
    17,371,8364.49
    Abbvie Inc
    ABBV US
    293,954
    17,360,9234.49
    Allergan Inc/United States
    AGN US
    97,690
    16,432,4354.25
    Shire Plc
    SHPG US
    63,271
    16,334,6744.22
    Astrazeneca Plc
    AZN US
    214,783
    16,048,5864.15
    Teva Pharmaceutical Industries Ltd
    TEVA US
    306,679
    15,996,3774.14
    Glaxosmithkline Plc
    GSK US
    326,194
    15,455,0724.00
    Mckesson Corp
    MCK US
    64,959
    12,718,3233.29
    Valeant Pharmaceuticals International I
    VRX US
    91,033
    10,690,0052.76
    Perrigo Co
    PRGO US
    41,586
    6,124,3701.58
    Zoetis Inc
    ZTS US
    157,621
    5,863,5011.52
    Mylan Inc/Pa
    MYL US
    121,826
    5,769,6791.49
    Mallinckrodt Plc
    MNK US
    31,769
    2,821,7230.73
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    40,976
    2,774,0750.72
    Hospira Inc
    HSP US
    46,880
    2,524,4880.65
    Salix Pharmaceuticals Ltd
    SLXP US
    13,700
    2,249,9510.58
    Other/Cash
    -518,730-0.13
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.